5-42611746-T-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000163.5(GHR):​c.71-17292T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.107 in 152,168 control chromosomes in the GnomAD database, including 1,267 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1267 hom., cov: 32)

Consequence

GHR
NM_000163.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.272

Publications

7 publications found
Variant links:
Genes affected
GHR (HGNC:4263): (growth hormone receptor) This gene encodes a member of the type I cytokine receptor family, which is a transmembrane receptor for growth hormone. Binding of growth hormone to the receptor leads to receptor dimerization and the activation of an intra- and intercellular signal transduction pathway leading to growth. Mutations in this gene have been associated with Laron syndrome, also known as the growth hormone insensitivity syndrome (GHIS), a disorder characterized by short stature. In humans and rabbits, but not rodents, growth hormone binding protein (GHBP) is generated by proteolytic cleavage of the extracellular ligand-binding domain from the mature growth hormone receptor protein. Multiple alternatively spliced transcript variants have been found for this gene.[provided by RefSeq, Jun 2011]
GHR Gene-Disease associations (from GenCC):
  • Laron syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • short stature due to partial GHR deficiency
    Inheritance: Unknown, AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.15 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000163.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GHR
NM_000163.5
MANE Select
c.71-17292T>G
intron
N/ANP_000154.1
GHR
NM_001242399.2
c.92-17292T>G
intron
N/ANP_001229328.1
GHR
NM_001242400.2
c.71-17292T>G
intron
N/ANP_001229329.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GHR
ENST00000230882.9
TSL:1 MANE Select
c.71-17292T>G
intron
N/AENSP00000230882.4
GHR
ENST00000620156.4
TSL:5
c.92-17292T>G
intron
N/AENSP00000483403.1
GHR
ENST00000537449.5
TSL:5
c.71-17292T>G
intron
N/AENSP00000442206.2

Frequencies

GnomAD3 genomes
AF:
0.107
AC:
16309
AN:
152050
Hom.:
1266
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0253
Gnomad AMI
AF:
0.194
Gnomad AMR
AF:
0.0984
Gnomad ASJ
AF:
0.0796
Gnomad EAS
AF:
0.000965
Gnomad SAS
AF:
0.0602
Gnomad FIN
AF:
0.224
Gnomad MID
AF:
0.0987
Gnomad NFE
AF:
0.153
Gnomad OTH
AF:
0.111
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.107
AC:
16305
AN:
152168
Hom.:
1267
Cov.:
32
AF XY:
0.109
AC XY:
8140
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0252
AC:
1047
AN:
41566
American (AMR)
AF:
0.0982
AC:
1500
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.0796
AC:
276
AN:
3468
East Asian (EAS)
AF:
0.000967
AC:
5
AN:
5172
South Asian (SAS)
AF:
0.0603
AC:
291
AN:
4826
European-Finnish (FIN)
AF:
0.224
AC:
2368
AN:
10568
Middle Eastern (MID)
AF:
0.0993
AC:
29
AN:
292
European-Non Finnish (NFE)
AF:
0.153
AC:
10378
AN:
67970
Other (OTH)
AF:
0.111
AC:
234
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
705
1410
2116
2821
3526
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.121
Hom.:
734
Bravo
AF:
0.0935
Asia WGS
AF:
0.0250
AC:
89
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.3
DANN
Benign
0.53
PhyloP100
-0.27
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13182117; hg19: chr5-42611848; API